Louis Nevejan

14PUBLICATIONS
18CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsAdolescent healthMajor global burdens of diseasePredictive and prognostic markersBioassays
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 28, 2026
Current Evidence for Integrating Mass Spectrometry into Clinical M-Protein Assessment in Plasma Cell Dyscrasias.

|Nov 20, 2023
Chronic myeloid leukemia (CML) in children and adolescents-Clinicopathological findings.

Louis Nevejan, Veerle Labarque, Nancy Boeckx

|Dec 23, 2022
Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts.

Louis Nevejan, Sien Ombelet, Lies Laenen

|Dec 06, 2022
Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care setting.

Louis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove

|Jul 05, 2022
Serum free light chain analysis: persisting limitations with new kids on the block.

Lieve Van Hoovels, Martine Vercammen, Louis Nevejan

|Jun 24, 2022
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.

Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse

Pageof 3

Frequent Collaborators

3 joint publications

Lieve Van Hoovels

2 joint publications

Lize Cuypers

1 joint publications

Nina Van Goethem

1 joint publications

Toon Braeye